App-Quantinova.ai

The dynamic functional role of triggering receptor expressed on myeloid cells 2 (TREM2) assessed with cerebrospinal fluid and positron emission tomography measures.

Harry Crook - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

18F-florbetapir

Type 2 diabetes mellitus and obesity impact AD-related pathology through overlapping and independent pathways.

Yang Yang Yu - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Mild cognitive impairment

Florbetapir

Does glucose metabolism dissociate from tau deposition in Alzheimer’s disease?

Joseph Nowell - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

AV-1451

Regional neuronal compensation in early and late stages of the Alzheimer’s trajectory

Joseph Nowell - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

AV-1451

Assessing inflammasome activity in mouse models of Down syndrome and organotypic brain slice cultures

Clíona Farrell - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Down syndrome

Nigericin

Ethnographic study of how care for long-term conditions is provided and supported in dementia

Jessica Rees - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Contributions of macrostructural and microstructural white matter damage to apathy in people with Alzheimer’s disease.

Riccardo Manca - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Heart rate variability: a novel biomarker for agitation propensity in Alzheimer's disease?

Kathy Y Liu - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Late life onset of persistent psychosis and incident dementia: risk stratification by baseline cognitive status

Amlish Munir - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

The longitudinal course and determinants of apathy in UK care home residents with dementia

Andrew Sommerlad - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Skill Building Blocks: Asynchronous Online Learning through Interactive Thematic Instruction

Nancy L Brown - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

A new synthesis of aberrant reward processing in frontotemporal dementias

Anthipa Chokesuwattanaskul - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body disease.

L. Wright - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Mild cognitive impairment

N/A

Mechanisms linking hearing loss with risk for dementia depends on age

Jochum J. van 't Hooft - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Novel unsupervised comprehensive tool for monitoring vascular cognitive impairment following stroke

Dragos Gruia - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Music in Dementia Assessment Scales (MiDAS) Portuguese version: translation, cultural adaptation and psychometric study

Lídia Sousa - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

- Memory clinic clinicians’ preferences and needs for communication with patients: A multi-national survey study from EU-FINGERS & LETHE projects

Heleen M.A. Hendriksen - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

Incremental diagnostic value of 18F-Fluetemetamol PET in differential diagnoses of AD-related neurodegenerative diseases from an unselected memory clinic cohort

Yiwen Bao - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

18F-flutemetamol

- Distinct patterns of neurodegeneration after TBI and in Alzheimer’s disease

Neil SN Graham - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Differences between healthy adults and mild cognitive impairment patients in Category Fluency performance: A scoring method based on words’ Serial Recall Order and item-level features

Matteo De Marco - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

Filters

45280 Abstracts